Browsing Tag
Yuviwel
1 post
BridgeBio targets achondroplasia market with first potential oral therapy as FDA fast-tracks infigratinib
BridgeBio’s oral infigratinib wins FDA Priority Review, setting up a February decision and potential challenge to injectable achondroplasia drugs.